Le Lézard
Classified in: Health, Business
Subjects: PER, CXP

Orchid Medical Announces Organizational Changes


ORLANDO, Fla., Oct. 2, 2019 /PRNewswire/ -- Orchid Medical (Orchid), one of the leading providers of ancillary medical management solutions in the workers' compensation industry announces Brian L. Carwile, president and CEO, transitioned to a new, active role as chairman of the board. Paul Taylor, Orchid's COO, has been appointed as the company's president and CEO. David Anderson, Orchid's vice president of operations, has been promoted to COO.

"Under Paul's leadership, our company has done a tremendous job in expanding our national footprint, enhancing our services and, most importantly, building a strong company culture," says Carwile. "My decision to pass the baton to Paul signifies my great faith in his ability to lead and inspire the next chapter of Orchid's growth."

Carwile founded Orchid Medical in 2002 and served as Orchid's president and CEO since inception. Under his leadership, the company evolved from a regional durable medical equipment (DME) provider to one of the fastest-growing providers of ancillary services and surgical cost containment solutions in the industry. The company has grown to over 100 employees serving more than 200 clients, including some of the largest insurance carriers and third-party administrators in the nation. Orchid has experienced double-digit growth and is on pace to achieve a second consecutive year of record-breaking sales performance.

For more than 12 years, Taylor has served as Orchid's COO providing executive leadership for the company's business operations, including finance, business development, client services, implementation, marketing, compliance, information technology and human resources. He is a workers' compensation industry veteran with over 20 years of experience in executive management positions. Prior to joining Orchid, Taylor founded a workers' compensation surveillance and investigations company, The Intel Group/Hyperion Risk, and served as the executive vice president until it was purchased in 2006. 

"As a leadership team, we have carefully considered the trajectory of our company's future, and we have a strategic, long-term plan for growth and overall success," says Taylor. "I am proud to take on the role of CEO, and I look forward to continuing to work alongside David as COO to build upon the strategy of driving Orchid's performance to the company's full potential."

David Anderson joined Orchid in 2007 as vice president of operations leading day-to-day operations and quality assurance. Throughout his tenure as vice president, he led Orchid's commitment to operational excellence by leveraging the company's proprietary technology to develop a unique client experience tailored to client-specific needs. Prior to Orchid, Anderson held the position of vice president of operations and special investigations at Hyperion Risk and Global Options.

Photos:
Paul Taylor: https://orchidmedical.com/wp-content/uploads/2019/10/Taylor_Paul_064.jpg 
David Anderson: https://orchidmedical.com/wp-content/uploads/2019/10/Anderson_David_017.jpg 
Brian Carwile: https://orchidmedical.com/wp-content/uploads/2019/10/Carwile_Brian_128.jpg

About Orchid Medical
Orchid Medical (Orchid) is a leading, nationwide provider of integrated ancillary and surgical cost containment solutions for the workers' compensation industry. Orchid works collaboratively with claims professionals and medical providers to cost-effectively manage and deliver the appropriate care and services injured workers need to recover. The company's medical management solutions include Surgical Cost Containment Program® (SCCP); DME and supplies; orthotics and prosthetics; home health and complex care; home and vehicle modifications; diagnostic imaging; physical medicine; and transportation and language services. For more information, visit www.ORCHIDmedical.com.

SOURCE Orchid Medical


These press releases may also interest you

25 avr 2024
AZZ Inc. , the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the pricing of its underwritten public offering of 4,000,000 shares of common stock at a public offering price per share of $70.00, for...

25 avr 2024
CarLotz, Inc.  Accused of Misleading Investors On March 29, 2024, the defendants' motion to dismiss in the pending securities class...

25 avr 2024
TSX VENTURE COMPANIES BULLETIN V2024-1200 LEONOVUS INC. ("LTV.WT")BULLETIN TYPE:  Warrant Expiry-DelistBULLETIN DATE:  April 25, 2024TSX Venture Tier 2 Company Effective at the opening, May 2, 2024, the Share Purchase Warrants of the Company will...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
Dominion Lending Centres Inc. ("DLCG" or the "Corporation") is pleased to announce that it has completed a sale of its 52% interest in Cape Communications International Inc. ("Impact") for aggregate cash proceeds of $3.71 million (the "Purchase...

25 avr 2024
Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) ("the Company" or "Orbia") today released unaudited results for the first quarter of 2024. Orbia's first quarter performance reflects the continued weakness in the market environment,...



News published on and distributed by: